News
Archive
Trellis Bioscience raises $9 million to advance clinical development of calpurbatug (TRL1068)
Paragraf growth designs accelerated with addition of industry heavyweights to Advisory Committee and Board of Directors
NASA awards PlanetiQ contract to expand access to Commercial Polarimetric GNSS Radio Occultation Satellite Data
Antevia Networks secures JOSCAR Accreditation as qualified supplier to aerospace, defence and security sectors
PlanetiQ advances atmospheric intelligence through high-performance GNSS-RO technology
Paragraf introduces PMF2000 GFET
Back To News
June 13, 2018
NorthSea Therapeutics
Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.